FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE

FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE was reported 36209 times

FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 RIGHT ATRIAL HYPERTROPHY 73 0.6636
1 INSPIRATORY CAPACITY ABNORMAL 17 0.6071
2 TOTAL LUNG CAPACITY INCREASED 154 0.5662
3 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 259 0.4952
4 ANTACID THERAPY 56 0.4308
5 SALPINGO-OOPHORECTOMY UNILATERAL 45 0.4091
6 EXPIRATORY RESERVE VOLUME DECREASED 22 0.3492
7 SLEEP DISORDER THERAPY 56 0.2828
8 APPENDICOLITH 86 0.2222
9 ANALGESIC THERAPY 70 0.2181
10 TOTAL LUNG CAPACITY ABNORMAL 80 0.2057
11 BRONCHIAL WALL THICKENING 147 0.2045
12 DRUG THERAPY 69 0.2035
13 ANTICOAGULANT THERAPY 56 0.1972
14 CAPILLARITIS 53 0.1920
15 EOSINOPHIL COUNT 22 0.1897
16 CONGENITAL HIATUS HERNIA 33 0.1447
17 MITE ALLERGY 89 0.1359
18 EOSINOPHILIC BRONCHITIS 27 0.1350
19 DUST ALLERGY 132 0.1346
20 PULMONARY VASCULITIS 71 0.1320
21 LUNG DIFFUSION DISORDER 20 0.1274
22 BACTEROIDES INFECTION 33 0.1264
23 SPIROMETRY ABNORMAL 73 0.1221
24 RESPIRATORY GAS EXCHANGE DISORDER 45 0.1213
25 PROLONGED EXPIRATION 31 0.1183
26 MALIGNANT MELANOMA STAGE 0 24 0.1148
27 SPUTUM PURULENT 73 0.1109
28 EOSINOPHILIC PNEUMONIA CHRONIC 32 0.1077
29 PULMONARY FUNCTION TEST ABNORMAL 166 0.1065
30 PRODUCT CONFUSION 79 0.0995
31 VITAL CAPACITY DECREASED 44 0.0982
32 OBSTRUCTIVE AIRWAYS DISORDER 1070 0.0961
33 LUNG HYPERINFLATION 78 0.0907
34 MYCOTIC ALLERGY 77 0.0901
35 VENOUS PRESSURE JUGULAR INCREASED 31 0.0854
36 RIGHT VENTRICULAR HYPERTROPHY 73 0.0808
37 BRONCHIAL OBSTRUCTION 111 0.0790
38 BRONCHIAL HYPERREACTIVITY 95 0.0790
39 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 57 0.0778
40 FORCED EXPIRATORY VOLUME DECREASED 217 0.0765
41 PRODUCT COMPLAINT 1882 0.0742
42 PRODUCT PACKAGING CONFUSION 179 0.0737
43 SMOKE SENSITIVITY 22 0.0714
44 NASAL POLYPS 346 0.0702
45 SINUSITIS FUNGAL 53 0.0661
46 CONJUNCTIVITIS ALLERGIC 97 0.0655
47 BRONCHIAL SECRETION RETENTION 83 0.0651
48 ATOPY 18 0.0647
49 RESPIRATORY SYMPTOM 184 0.0646
50 VOCAL CORD DYSFUNCTION 31 0.0629
51 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 1041 0.0612
52 INTERCEPTED DRUG PRESCRIBING ERROR 30 0.0607
53 BRONCHIECTASIS 403 0.0598
54 REVERSIBLE AIRWAYS OBSTRUCTION 29 0.0571
55 EOSINOPHIL COUNT ABNORMAL 41 0.0549
56 FULL BLOOD COUNT ABNORMAL 574 0.0542
57 OESOPHAGEAL SPASM 99 0.0537
58 FORCED VITAL CAPACITY DECREASED 35 0.0536
59 SPUTUM INCREASED 114 0.0527
60 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 106 0.0519
61 PERFUME SENSITIVITY 29 0.0510
62 NEURITIS 78 0.0505
63 LUNG DIFFUSION TEST DECREASED 20 0.0501
64 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 2341 0.0501
65 LUNG ADENOCARCINOMA STAGE IV 19 0.0499
66 PRODUCT LABEL CONFUSION 288 0.0494
67 SPUTUM DISCOLOURED 456 0.0480
68 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 44 0.0475
69 WHEEZING 2688 0.0453
70 RESTRICTIVE PULMONARY DISEASE 53 0.0452
71 TOTAL LUNG CAPACITY DECREASED 71 0.0444
72 PLEURAL THICKENING 30 0.0439
73 ALLERGY TO ANIMAL 45 0.0422
74 RHINITIS ALLERGIC 188 0.0422
75 AORTIC VALVE STENOSIS 75 0.0420
76 DIASTOLIC DYSFUNCTION 128 0.0414
77 RESPIRATORY TRACT INFLAMMATION 19 0.0408
78 PRECANCEROUS CONDITION 27 0.0403
79 INCREASED BRONCHIAL SECRETION 100 0.0391
80 INTERCEPTED DRUG ADMINISTRATION ERROR 17 0.0387
81 HYPERPHOSPHATAEMIA 82 0.0381
82 OBSTRUCTIVE SLEEP APNOEA SYNDROME 53 0.0363
83 ASTHMA 4061 0.0359
84 SARCOIDOSIS 169 0.0355
85 SECONDARY IMMUNODEFICIENCY 43 0.0354
86 INHALATION THERAPY 22 0.0349
87 BLOOD IMMUNOGLOBULIN E INCREASED 84 0.0347
88 BLOOD COUNT ABNORMAL 522 0.0344
89 RHONCHI 47 0.0340
90 CHRONIC SINUSITIS 123 0.0327
91 LUNG OPACITY 86 0.0326
92 DEVICE USE CONFUSION 17 0.0325
93 PULMONARY FUNCTION TEST DECREASED 141 0.0322
94 NASAL OBSTRUCTION 60 0.0320
95 EMERGENCY CARE EXAMINATION 21 0.0310
96 LOWER RESPIRATORY TRACT CONGESTION 52 0.0306
97 BLOOD PHOSPHORUS INCREASED 83 0.0304
98 FEMALE GENITAL TRACT FISTULA 51 0.0298
99 HAEMOPHILUS INFECTION 29 0.0296
100 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1395 0.0290
101 NASAL DISCHARGE DISCOLOURATION 40 0.0290
102 RESPIRATORY TRACT IRRITATION 30 0.0287
103 SINUS PAIN 66 0.0283
104 JAUNDICE CHOLESTATIC 99 0.0280
105 OESOPHAGEAL PAIN 110 0.0278
106 BRONCHIAL DISORDER 43 0.0276
107 RECTAL PROLAPSE 33 0.0273
108 DRUG DISPENSING ERROR 416 0.0272
109 KYPHOSIS 47 0.0266
110 HYPOMANIA 96 0.0261
111 INFUSION SITE DISCHARGE 45 0.0256
112 OBSTRUCTION 101 0.0253
113 CHEST X-RAY ABNORMAL 77 0.0251
114 LUNG OPERATION 21 0.0251
115 HILAR LYMPHADENOPATHY 22 0.0250
116 UPPER-AIRWAY COUGH SYNDROME 206 0.0250
117 PRODUCTIVE COUGH 1181 0.0247
118 NORMOCHROMIC NORMOCYTIC ANAEMIA 74 0.0246
119 BREATH SOUNDS ABNORMAL 121 0.0245
120 THROAT CLEARING 91 0.0243
121 AORTIC STENOSIS 84 0.0241
122 INTENTIONAL UNDERDOSE 176 0.0241
123 CANDIDA INFECTION 398 0.0235
124 DEVICE USE ERROR 793 0.0228
125 LUNG CONSOLIDATION 63 0.0225
126 EOSINOPHIL COUNT INCREASED 186 0.0223
127 CARBON DIOXIDE INCREASED 30 0.0220
128 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1553 0.0218
129 EMPHYSEMA 220 0.0218
130 IDIOPATHIC INTRACRANIAL HYPERTENSION 49 0.0218
131 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1125 0.0215
132 CARDIAC MURMUR 185 0.0214
133 MYCOBACTERIUM AVIUM COMPLEX INFECTION 57 0.0212
134 DYSPHONIA 1240 0.0212
135 NOCTURNAL DYSPNOEA 27 0.0212
136 MULTIPLE ALLERGIES 164 0.0209
137 STEROID DEPENDENCE 18 0.0205
138 BENIGN PROSTATIC HYPERPLASIA 105 0.0203
139 INFUSION SITE MASS 22 0.0202
140 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 17 0.0202
141 TACHYARRHYTHMIA 50 0.0200
142 OROPHARYNGEAL CANDIDIASIS 18 0.0199
143 DYSPNOEA EXERTIONAL 745 0.0198
144 TERMINAL INSOMNIA 35 0.0198
145 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 174 0.0197
146 INFUSION SITE BRUISING 41 0.0190
147 HYPOSMIA 28 0.0186
148 SLEEP APNOEA SYNDROME 347 0.0182
149 PLEURITIC PAIN 50 0.0181
150 NASAL OEDEMA 32 0.0177
151 SINUS OPERATION 42 0.0176
152 SPUTUM RETENTION 17 0.0172
153 ARTERIOSCLEROSIS CORONARY ARTERY 113 0.0170
154 NASAL SEPTUM DEVIATION 33 0.0169
155 EMBOLISM VENOUS 51 0.0168
156 ORAL CANDIDIASIS 221 0.0168
157 LYMPHOEDEMA 114 0.0165
158 OXYGEN THERAPY 27 0.0164
159 SEASONAL ALLERGY 232 0.0164
160 PULMONARY MASS 243 0.0163
161 NEUROLOGICAL SYMPTOM 93 0.0163
162 NASAL INFLAMMATION 17 0.0161
163 RHINITIS 129 0.0160
164 IRON DEFICIENCY 71 0.0158
165 STAPHYLOCOCCUS TEST POSITIVE 33 0.0156
166 INFUSION SITE WARMTH 19 0.0155
167 SECRETION DISCHARGE 194 0.0155
168 MIDDLE INSOMNIA 289 0.0155
169 APHONIA 209 0.0150
170 BLOOD URIC ACID INCREASED 86 0.0149
171 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 75 0.0148
172 PULMONARY PAIN 43 0.0147
173 HYPOPNOEA 50 0.0144
174 PRODUCT DISPENSING ERROR 312 0.0143
175 RALES 83 0.0143
176 INABILITY TO AFFORD MEDICATION 140 0.0141
177 OXYGEN SATURATION ABNORMAL 40 0.0141
178 ISCHAEMIC CARDIOMYOPATHY 43 0.0140
179 RESPIRATION ABNORMAL 96 0.0139
180 NASAL DISORDER 37 0.0139
181 BLOOD TEST ABNORMAL 193 0.0137
182 VOCAL CORD DISORDER 27 0.0137
183 HIATUS HERNIA 177 0.0137
184 INTERCEPTED MEDICATION ERROR 62 0.0134
185 PRESCRIBED OVERDOSE 257 0.0133
186 GRANULOMATOSIS WITH POLYANGIITIS 16 0.0133
187 PULMONARY ALVEOLAR HAEMORRHAGE 74 0.0132
188 RESPIRATORY TRACT CONGESTION 209 0.0131
189 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 79 0.0128
190 INFUSION SITE HAEMORRHAGE 42 0.0128
191 INFUSION SITE PRURITUS 40 0.0127
192 INFUSION SITE SWELLING 78 0.0124
193 COUGH 3458 0.0123
194 SUFFOCATION FEELING 30 0.0121
195 REHABILITATION THERAPY 46 0.0119
196 CHEST DISCOMFORT 1205 0.0118
197 IMPAIRED QUALITY OF LIFE 169 0.0117
198 BLOOD PRESSURE SYSTOLIC ABNORMAL 29 0.0117
199 OXYGEN CONSUMPTION INCREASED 28 0.0117
200 TONGUE COATED 20 0.0116
201 BRONCHITIS 844 0.0114
202 GASTROINTESTINAL WALL THICKENING 17 0.0113
203 PULMONARY CONGESTION 149 0.0113
204 HYPOPHOSPHATAEMIA 83 0.0112
205 MYASTHENIA GRAVIS 90 0.0111
206 TONGUE DISCOMFORT 47 0.0111
207 DYSPNOEA 6235 0.0110
208 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO DEVICE USE ERROR 26 0.0109
209 ESSENTIAL HYPERTENSION 20 0.0109
210 BILIARY DILATATION 16 0.0109
211 OTORRHOEA 19 0.0109
212 RENAL NEOPLASM 23 0.0108
213 UPPER RESPIRATORY TRACT CONGESTION 31 0.0107
214 EXERCISE TOLERANCE DECREASED 60 0.0104
215 PRODUCT DOSE OMISSION 673 0.0103
216 APPENDICITIS 96 0.0103
217 SINUS CONGESTION 138 0.0102
218 EXTRA DOSE ADMINISTERED 412 0.0102
219 BUNDLE BRANCH BLOCK LEFT 43 0.0101
220 INFUSION SITE ERYTHEMA 85 0.0101
221 SENSITIVITY TO WEATHER CHANGE 53 0.0101
222 INTERVERTEBRAL DISC DEGENERATION 93 0.0100
223 TROPONIN INCREASED 76 0.0100
224 NASAL CONGESTION 581 0.0099
225 THROAT IRRITATION 442 0.0098
226 GOUT 176 0.0098
227 SNORING 37 0.0098
228 INFUSION SITE INFECTION 22 0.0095
229 PARANASAL SINUS HYPERSECRETION 36 0.0094
230 SINUS DISORDER 185 0.0093
231 VENTRICULAR HYPERTROPHY 23 0.0092
232 LUNG DISORDER 448 0.0091
233 BRONCHITIS CHRONIC 22 0.0090
234 IRON DEFICIENCY ANAEMIA 83 0.0090
235 INCREASED UPPER AIRWAY SECRETION 46 0.0090
236 EOSINOPHILIA 157 0.0090
237 CATARACT OPERATION 53 0.0089
238 LYMPHADENOPATHY MEDIASTINAL 17 0.0089
239 ARTERIOSCLEROSIS 83 0.0088
240 BACTERIAL INFECTION 164 0.0088
241 ORAL FUNGAL INFECTION 24 0.0088
242 ASTHMATIC CRISIS 32 0.0088
243 PULMONARY FIBROSIS 165 0.0086
244 DRY THROAT 87 0.0086
245 SCHIZOPHRENIA 103 0.0085
246 CUSHINGOID 27 0.0084
247 CREPITATIONS 25 0.0084
248 RHINORRHOEA 542 0.0084
249 HAEMOPTYSIS 230 0.0082
250 BLOOD PRESSURE DIASTOLIC INCREASED 38 0.0082
251 OROPHARYNGEAL PAIN 762 0.0082
252 COLONOSCOPY 18 0.0082
253 NECK SURGERY 19 0.0082
254 INFUSION SITE PAIN 105 0.0081
255 DEVICE INFUSION ISSUE 20 0.0081
256 LOWER RESPIRATORY TRACT INFECTION 366 0.0080
257 TONGUE DISCOLOURATION 35 0.0080
258 DECREASED ACTIVITY 86 0.0080
259 RESPIRATORY DISORDER 237 0.0079
260 LUNG NEOPLASM MALIGNANT 325 0.0079
261 DIVERTICULUM 56 0.0079
262 GASTROOESOPHAGEAL REFLUX DISEASE 634 0.0079
263 VASCULITIS 91 0.0078
264 TRICUSPID VALVE INCOMPETENCE 62 0.0078
265 CHOKING SENSATION 43 0.0078
266 NODULE 100 0.0077
267 PARANASAL SINUS DISCOMFORT 29 0.0077
268 HYPERVENTILATION 44 0.0076
269 EMERGENCY CARE 23 0.0076
270 OSTEOPOROSIS 309 0.0075
271 LUNG NEOPLASM 32 0.0075
272 EAR CONGESTION 20 0.0074
273 SKIN ATROPHY 42 0.0073
274 PHARYNGEAL DISORDER 21 0.0073
275 ATELECTASIS 70 0.0072
276 HYPERPARATHYROIDISM SECONDARY 18 0.0072
277 STRIDOR 21 0.0071
278 EAR PRURITUS 25 0.0071
279 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 240 0.0071
280 OROPHARYNGEAL DISCOMFORT 64 0.0071
281 VENTRICULAR FIBRILLATION 78 0.0070
282 AORTIC ARTERIOSCLEROSIS 18 0.0070
283 PNEUMONIA 2247 0.0069
284 SINUSITIS 700 0.0068
285 EXPIRED PRODUCT ADMINISTERED 224 0.0067
286 BLOOD CALCIUM INCREASED 59 0.0067
287 BLOOD PRESSURE DIASTOLIC ABNORMAL 17 0.0067
288 LUNG INFILTRATION 59 0.0067
289 RESPIRATORY TRACT INFECTION 173 0.0066
290 UPPER RESPIRATORY TRACT INFECTION 306 0.0066
291 OXYGEN SATURATION DECREASED 372 0.0066
292 RED BLOOD CELL COUNT INCREASED 18 0.0065
293 VIRAL UPPER RESPIRATORY TRACT INFECTION 31 0.0065
294 CARDIOGENIC SHOCK 93 0.0065
295 HYSTERECTOMY 56 0.0065
296 CHOKING 126 0.0065
297 INTENTIONAL DEVICE MISUSE 28 0.0063
298 DRUG PRESCRIBING ERROR 122 0.0063
299 FRUSTRATION TOLERANCE DECREASED 51 0.0063
300 POLYP 41 0.0063
301 OBESITY 99 0.0062
302 DYSPNOEA AT REST 18 0.0062
303 PRODUCT DOSE OMISSION ISSUE 1827 0.0062
304 HYPERLIPIDAEMIA 74 0.0062
305 TOOTH ABSCESS 63 0.0062
306 EOSINOPHILIC OESOPHAGITIS 17 0.0061
307 PRODUCT QUALITY ISSUE 822 0.0060
308 NEPHROGENIC ANAEMIA 28 0.0060
309 CARDIAC PACEMAKER INSERTION 36 0.0060
310 BRONCHOSPASM 86 0.0060
311 ATYPICAL PNEUMONIA 18 0.0060
312 SNEEZING 134 0.0060
313 END STAGE RENAL DISEASE 108 0.0059
314 CORONAVIRUS INFECTION 39 0.0059
315 FIBROMYALGIA 143 0.0059
316 RESPIRATORY SYNCYTIAL VIRUS INFECTION 51 0.0059
317 SPINAL OPERATION 72 0.0058
318 ANOSMIA 82 0.0057
319 EYE OPERATION 26 0.0056
320 RESPIRATORY RATE INCREASED 50 0.0056
321 EAR INFECTION 149 0.0056
322 BRONCHOPULMONARY ASPERGILLOSIS 43 0.0055
323 ORAL DISCOMFORT 77 0.0055
324 ANTINUCLEAR ANTIBODY POSITIVE 18 0.0055
325 NICOTINE DEPENDENCE 43 0.0055
326 CYSTITIS 175 0.0055
327 ORAL PAIN 123 0.0055
328 UNDERDOSE 398 0.0054
329 NEURALGIA 132 0.0054
330 LYME DISEASE 18 0.0054
331 PNEUMOTHORAX 85 0.0054
332 INFLUENZA 590 0.0053
333 DRUG DOSE OMISSION 871 0.0053
334 EYE INJURY 16 0.0053
335 INTENTIONAL DOSE OMISSION 150 0.0053
336 ECCHYMOSIS 36 0.0052
337 FUNGAL INFECTION 175 0.0052
338 ANEURYSM 26 0.0052
339 OSTEOPENIA 79 0.0052
340 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 37 0.0052
341 FEELING JITTERY 98 0.0051
342 ORAL INFECTION 20 0.0051
343 PHARYNGEAL SWELLING 49 0.0050
344 HYPOXIA 175 0.0050
345 BACK INJURY 54 0.0050
346 DRUG EFFECT INCOMPLETE 180 0.0050
347 ORAL DISORDER 36 0.0049
348 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 84 0.0049
349 LUNG INFECTION 76 0.0049
350 JOINT INJURY 104 0.0049
351 SKIN ABRASION 23 0.0049
352 DERMATITIS CONTACT 55 0.0048
353 INTENTIONAL PRODUCT MISUSE 422 0.0048
354 PNEUMONIA BACTERIAL 44 0.0048
355 SKIN LACERATION 52 0.0048
356 CONCUSSION 37 0.0048
357 HEART RATE INCREASED 470 0.0047
358 MUSCULOSKELETAL CHEST PAIN 73 0.0047
359 ULCER 75 0.0047
360 GINGIVAL DISORDER 18 0.0047
361 HEPATOTOXICITY 104 0.0047
362 PRODUCT PRESCRIBING ERROR 111 0.0047
363 NERVE COMPRESSION 43 0.0047
364 INFUSION SITE EXTRAVASATION 29 0.0047
365 DRY MOUTH 377 0.0046
366 ILL-DEFINED DISORDER 281 0.0046
367 NASOPHARYNGITIS 849 0.0046
368 LUMBAR VERTEBRAL FRACTURE 21 0.0046
369 AGEUSIA 114 0.0046
370 LIGAMENT SPRAIN 45 0.0045
371 CONJUNCTIVITIS 84 0.0045
372 ILLNESS 466 0.0045
373 SLEEP DISORDER 319 0.0045
374 OESOPHAGEAL CANDIDIASIS 18 0.0045
375 EYE INFECTION 51 0.0045
376 SYMPTOM RECURRENCE 27 0.0045
377 MOUTH SWELLING 26 0.0045
378 COVID-19 PNEUMONIA 53 0.0045
379 BLOOD PRESSURE DIASTOLIC DECREASED 33 0.0045
380 CATARACT 266 0.0045
381 CARDIAC OPERATION 38 0.0044
382 PRODUCT COMMUNICATION ISSUE 39 0.0044
383 HEART RATE DECREASED 155 0.0044
384 PRODUCT USE IN UNAPPROVED INDICATION 1083 0.0044
385 BLOOD PRESSURE SYSTOLIC INCREASED 85 0.0044
386 CORONARY ARTERIAL STENT INSERTION 22 0.0043
387 ANAL INCONTINENCE 39 0.0043
388 VIRAL INFECTION 144 0.0043
389 FOOD POISONING 23 0.0043
390 ATRIAL FIBRILLATION 418 0.0043
391 WRIST FRACTURE 51 0.0043
392 INCORRECT DRUG ADMINISTRATION RATE 18 0.0042
393 ABDOMINAL TENDERNESS 21 0.0042
394 MENISCUS INJURY 26 0.0042
395 FLUID RETENTION 215 0.0042
396 BLOOD BILIRUBIN INCREASED 114 0.0042
397 INSURANCE ISSUE 64 0.0042
398 OSTEOARTHRITIS 176 0.0041
399 TONGUE DISORDER 30 0.0041
400 ASPIRATION 45 0.0041
401 SOCIAL PROBLEM 17 0.0041
402 HAND FRACTURE 29 0.0041
403 RIB FRACTURE 84 0.0041
404 PRODUCT ADMINISTRATION INTERRUPTED 32 0.0041
405 UPPER LIMB FRACTURE 81 0.0041
406 EAR PAIN 79 0.0041
407 RENAL CYST 32 0.0040
408 CHOLELITHIASIS 132 0.0040
409 PANIC REACTION 29 0.0040
410 RETCHING 85 0.0040
411 STOMATITIS 241 0.0040
412 STENT PLACEMENT 32 0.0040
413 HYPOTHYROIDISM 126 0.0039
414 MACULAR DEGENERATION 47 0.0039
415 PSYCHOTIC DISORDER 116 0.0039
416 PRODUCT TASTE ABNORMAL 53 0.0039
417 PLEURISY 23 0.0039
418 SINUS HEADACHE 23 0.0039
419 HOSPITALISATION 592 0.0038
420 MICTURITION URGENCY 44 0.0038
421 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 694 0.0038
422 OEDEMA PERIPHERAL 469 0.0038
423 CATHETERISATION CARDIAC 17 0.0038
424 BLOOD PRESSURE INCREASED 581 0.0038
425 EAR DISCOMFORT 39 0.0038
426 BOWEL MOVEMENT IRREGULARITY 29 0.0038
427 THROAT TIGHTNESS 102 0.0038
428 CHEST PAIN 691 0.0037
429 HEREDITARY ANGIOEDEMA 40 0.0037
430 CONCOMITANT DISEASE AGGRAVATED 23 0.0037
431 POOR QUALITY SLEEP 80 0.0037
432 ADRENAL INSUFFICIENCY 45 0.0037
433 FACIAL PAIN 33 0.0037
434 HIP SURGERY 20 0.0037
435 SWOLLEN TONGUE 115 0.0037
436 CONDITION AGGRAVATED 1116 0.0037
437 FEEDING DISORDER 74 0.0036
438 HYPOACUSIS 157 0.0036
439 ARTHROPOD BITE 27 0.0036
440 FOOT FRACTURE 69 0.0036
441 TIBIA FRACTURE 17 0.0036
442 DIABETES MELLITUS 274 0.0036
443 ACUTE RESPIRATORY FAILURE 69 0.0036
444 GLAUCOMA 69 0.0036
445 POST-TRAUMATIC STRESS DISORDER 24 0.0036
446 HEART RATE IRREGULAR 80 0.0035
447 CARDIOMEGALY 43 0.0035
448 DISEASE RECURRENCE 166 0.0035
449 DRUG INTOLERANCE 337 0.0035
450 COVID-19 612 0.0035
451 PULMONARY THROMBOSIS 38 0.0035
452 ORAL HERPES 68 0.0035
453 TINNITUS 160 0.0035
454 POOR VENOUS ACCESS 36 0.0035
455 PARAESTHESIA ORAL 50 0.0035
456 BLOOD IRON DECREASED 41 0.0035
457 PULMONARY EMBOLISM 328 0.0034
458 CARDIOMYOPATHY 51 0.0034
459 PALPITATIONS 403 0.0034
460 WEIGHT FLUCTUATION 36 0.0034
461 GASTROENTERITIS VIRAL 62 0.0034
462 EYE PRURITUS 115 0.0034
463 FLANK PAIN 32 0.0034
464 DIZZINESS POSTURAL 33 0.0034
465 GINGIVAL PAIN 27 0.0034
466 OCULAR DISCOMFORT 38 0.0034
467 MALAISE 1479 0.0034
468 BLOOD PRESSURE ABNORMAL 67 0.0034
469 ASCITES 99 0.0034
470 THERAPEUTIC RESPONSE UNEXPECTED 151 0.0034
471 CARDIAC FAILURE CONGESTIVE 270 0.0034
472 ANKLE FRACTURE 52 0.0034
473 BODY TEMPERATURE DECREASED 33 0.0033
474 NASAL DRYNESS 21 0.0033
475 LIMB INJURY 91 0.0033
476 PRODUCT USE ISSUE 629 0.0033
477 THROMBOSIS 269 0.0033
478 PRODUCT DISTRIBUTION ISSUE 31 0.0033
479 MIGRAINE 317 0.0033
480 JOINT DISLOCATION 35 0.0033
481 ECZEMA 172 0.0033
482 AORTIC ANEURYSM 25 0.0033
483 HYPERTENSION 696 0.0033
484 PRODUCT DOSE OMISSION IN ERROR 93 0.0033
485 BLOOD URINE PRESENT 62 0.0033
486 THERAPEUTIC RESPONSE DECREASED 198 0.0033
487 HEAD INJURY 103 0.0033
488 HOSPICE CARE 32 0.0032
489 FOOD ALLERGY 25 0.0032
490 PHARYNGITIS STREPTOCOCCAL 35 0.0032
491 LACRIMATION INCREASED 97 0.0032
492 LARGE INTESTINE POLYP 22 0.0032
493 PRODUCT RESIDUE PRESENT 17 0.0031
494 GASTROENTERITIS 46 0.0031
495 PSEUDOMONAS INFECTION 27 0.0031
496 DIVERTICULITIS 87 0.0031
497 KNEE ARTHROPLASTY 66 0.0031
498 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 17 0.0031
499 THYROID DISORDER 48 0.0031
500 DRUG INEFFECTIVE 4089 0.0031
501 CARDIAC FLUTTER 20 0.0031
502 SCAB 35 0.0031
503 HEAD DISCOMFORT 54 0.0030
504 DYSPEPSIA 300 0.0030
505 SPINAL FRACTURE 61 0.0030
506 PRE-EXISTING CONDITION IMPROVED 19 0.0030
507 NERVOUSNESS 159 0.0030
508 MULTIPLE ORGAN DYSFUNCTION SYNDROME 86 0.0030
509 SARS-COV-2 TEST POSITIVE 40 0.0030
510 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 613 0.0030
511 GASTROINTESTINAL INFECTION 27 0.0030
512 VITAMIN D DEFICIENCY 29 0.0030
513 SENSATION OF FOREIGN BODY 25 0.0030
514 WRONG PRODUCT ADMINISTERED 20 0.0030
515 TOOTH INFECTION 39 0.0030
516 KNEE OPERATION 29 0.0029
517 GLOSSODYNIA 66 0.0029
518 SCRATCH 31 0.0029
519 PULMONARY OEDEMA 131 0.0029
520 PAROSMIA 22 0.0029
521 MUSCULOSKELETAL DISCOMFORT 50 0.0029
522 KIDNEY INFECTION 57 0.0029
523 SPINAL COMPRESSION FRACTURE 24 0.0029
524 ASPERGILLUS INFECTION 19 0.0029
525 PERIPHERAL SWELLING 444 0.0029
526 URTICARIA 481 0.0029
527 CARDIAC DISORDER 268 0.0029
528 HIP FRACTURE 92 0.0029
529 ARTHRITIS 225 0.0029
530 FEELING COLD 79 0.0028
531 ANXIETY 807 0.0028
532 BLOOD PRESSURE FLUCTUATION 68 0.0028
533 PELVIC FRACTURE 22 0.0028
534 BLOOD CHOLESTEROL INCREASED 131 0.0028
535 ABDOMINAL DISTENSION 293 0.0028
536 HYPERSENSITIVITY 521 0.0028
537 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 17 0.0028
538 DERMATITIS ATOPIC 147 0.0028
539 OEDEMA 151 0.0028
540 OCULAR HYPERAEMIA 132 0.0028
541 HERNIA 53 0.0027
542 EXOSTOSIS 25 0.0027
543 OVERDOSE 587 0.0027
544 GLUCOSE TOLERANCE IMPAIRED 16 0.0027
545 EYE DISCHARGE 28 0.0027
546 TERMINAL STATE 18 0.0027
547 CELLULITIS 134 0.0027
548 MUSCLE STRAIN 23 0.0027
549 TOOTH EXTRACTION 33 0.0026
550 NASAL DISCOMFORT 21 0.0026
551 ADVERSE REACTION 35 0.0026
552 SPINAL OSTEOARTHRITIS 23 0.0026
553 SWELLING 245 0.0026
554 PLEURAL EFFUSION 159 0.0026
555 FEELING ABNORMAL 618 0.0026
556 TRANSIENT ISCHAEMIC ATTACK 87 0.0026
557 URINARY TRACT INFECTION 438 0.0026
558 CLOSTRIDIUM DIFFICILE INFECTION 56 0.0026
559 PAIN IN EXTREMITY 752 0.0025
560 PULMONARY HYPERTENSION 53 0.0025
561 THERAPY CHANGE 25 0.0025
562 FALL 843 0.0025
563 BACK DISORDER 41 0.0025
564 DRUG ADMINISTRATION ERROR 77 0.0025
565 DRY EYE 125 0.0025
566 INTRAOCULAR PRESSURE INCREASED 32 0.0025
567 DIZZINESS 1248 0.0025
568 BLOOD POTASSIUM DECREASED 75 0.0025
569 PRODUCT STORAGE ERROR 218 0.0025
570 INSOMNIA 663 0.0025
571 NECK PAIN 139 0.0025
572 HYPERCHOLESTEROLAEMIA 24 0.0025
573 HIP ARTHROPLASTY 38 0.0025
574 SURGERY 145 0.0025
575 NOCTURIA 30 0.0025
576 PHARYNGEAL OEDEMA 38 0.0025
577 AUTOIMMUNE DISORDER 24 0.0025
578 SCIATICA 39 0.0024
579 SENSITIVE SKIN 18 0.0024
580 PRODUCT PRESCRIBING ISSUE 53 0.0024
581 BODY HEIGHT DECREASED 26 0.0024
582 VISION BLURRED 333 0.0024
583 IMPAIRED GASTRIC EMPTYING 33 0.0024
584 ABDOMINAL PAIN 563 0.0024
585 HERPES ZOSTER 139 0.0024
586 APPETITE DISORDER 16 0.0024
587 INFECTION 349 0.0024
588 EYE PAIN 136 0.0024
589 WEIGHT DECREASED 672 0.0024
590 SKIN INFECTION 27 0.0024
591 EXPOSURE VIA SKIN CONTACT 62 0.0024
592 PRESYNCOPE 58 0.0024
593 CONSTIPATION 518 0.0024
594 INTENTIONAL PRODUCT USE ISSUE 208 0.0024
595 ADVERSE DRUG REACTION 213 0.0024
596 TREMOR 392 0.0024
597 RENAL PAIN 25 0.0024
598 NERVE INJURY 26 0.0023
599 BLOOD SODIUM DECREASED 44 0.0023
600 LIVER FUNCTION TEST INCREASED 50 0.0023
601 GAIT INABILITY 77 0.0023
602 SEPSIS 256 0.0023
603 NEPHROLITHIASIS 105 0.0023
604 DEVICE USE ISSUE 40 0.0023
605 PRODUCT USE COMPLAINT 36 0.0023
606 DEVICE OCCLUSION 32 0.0023
607 FATIGUE 1769 0.0023
608 MYOCARDIAL INFARCTION 396 0.0023
609 TOOTH FRACTURE 25 0.0023
610 DRUG EFFECT DECREASED 122 0.0023
611 TOOTHACHE 41 0.0023
612 DISCOMFORT 138 0.0023
613 ASTHENIA 850 0.0023
614 ROTATOR CUFF SYNDROME 29 0.0023
615 EYE DISORDER 74 0.0022
616 PERICARDIAL EFFUSION 52 0.0022
617 BACK PAIN 522 0.0022
618 WEIGHT INCREASED 503 0.0022
619 DYSPHAGIA 213 0.0022
620 CONTUSION 216 0.0022
621 PRODUCT AVAILABILITY ISSUE 51 0.0022
622 LOCALISED INFECTION 54 0.0022
623 SQUAMOUS CELL CARCINOMA 21 0.0022
624 DRUG EFFECT LESS THAN EXPECTED 33 0.0022
625 GAIT DISTURBANCE 425 0.0022
626 CHILLS 260 0.0022
627 INCORRECT PRODUCT STORAGE 29 0.0022
628 EYE IRRITATION 127 0.0022
629 BLOOD MAGNESIUM DECREASED 19 0.0022
630 TRANSFUSION 23 0.0022
631 PANIC ATTACK 80 0.0022
632 DEMENTIA 61 0.0022
633 JOINT SWELLING 263 0.0022
634 ACCIDENT 26 0.0022
635 ROAD TRAFFIC ACCIDENT 91 0.0022
636 HEADACHE 1363 0.0022
637 DENTAL CARIES 24 0.0022
638 TOOTH DISORDER 48 0.0022
639 DEVICE DELIVERY SYSTEM ISSUE 59 0.0022
640 DYSGEUSIA 160 0.0022
641 FEELING HOT 132 0.0022
642 PULMONARY ARTERIAL HYPERTENSION 31 0.0021
643 SKIN CANCER 46 0.0021
644 VITREOUS FLOATERS 21 0.0021
645 SKIN REACTION 30 0.0021
646 URINARY RETENTION 71 0.0021
647 TENDERNESS 22 0.0021
648 VITAMIN D DECREASED 18 0.0021
649 INTERVERTEBRAL DISC PROTRUSION 46 0.0021
650 LIMB DISCOMFORT 65 0.0021
651 HALLUCINATION 158 0.0021
652 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 115 0.0021
653 LOWER LIMB FRACTURE 40 0.0021
654 GASTROINTESTINAL DISORDER 186 0.0021
655 THIRST 37 0.0021
656 RESPIRATORY DISTRESS 57 0.0021
657 LYMPHADENOPATHY 73 0.0021
658 SLUGGISHNESS 21 0.0021
659 AGITATION 150 0.0020
660 SPEECH DISORDER 107 0.0020
661 MUSCLE SPASMS 374 0.0020
662 ABDOMINAL PAIN UPPER 418 0.0020
663 PRODUCT ADMINISTRATION ERROR 41 0.0020
664 DEPRESSION 460 0.0020
665 PHARYNGITIS 25 0.0020
666 CHOLECYSTECTOMY 23 0.0020
667 LIP SWELLING 67 0.0020
668 TREATMENT NONCOMPLIANCE 110 0.0020
669 CHRONIC KIDNEY DISEASE 152 0.0020
670 HYPOKINESIA 29 0.0020
671 ACCIDENTAL OVERDOSE 73 0.0020
672 HEPATIC ENZYME INCREASED 136 0.0020
673 THERAPEUTIC RESPONSE SHORTENED 66 0.0020
674 EPISTAXIS 148 0.0020
675 TACHYCARDIA 175 0.0020
676 CORONARY ARTERY OCCLUSION 27 0.0020
677 POLLAKIURIA 82 0.0020
678 PRURITUS 751 0.0020
679 INITIAL INSOMNIA 20 0.0019
680 MULTIPLE FRACTURES 32 0.0019
681 LYMPHOMA 30 0.0019
682 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 138 0.0019
683 QUALITY OF LIFE DECREASED 26 0.0019
684 NEUROPATHY PERIPHERAL 184 0.0019
685 ATRIAL SEPTAL DEFECT 16 0.0019
686 ARTHRALGIA 792 0.0019
687 VISUAL IMPAIRMENT 236 0.0019
688 HYPONATRAEMIA 107 0.0019
689 RASH 827 0.0019
690 ABDOMINAL DISCOMFORT 317 0.0019
691 DYSURIA 69 0.0019
692 MUSCULOSKELETAL STIFFNESS 164 0.0019
693 IRRITABLE BOWEL SYNDROME 40 0.0019
694 CARPAL TUNNEL SYNDROME 26 0.0019
695 EYE SWELLING 69 0.0019
696 BONE PAIN 108 0.0018
697 SWELLING FACE 120 0.0018
698 BIPOLAR DISORDER 20 0.0018
699 HYPERHIDROSIS 237 0.0018
700 HYPERSOMNIA 52 0.0018
701 OFF LABEL USE 1587 0.0018
702 VOMITING 851 0.0018
703 ANAPHYLACTIC REACTION 100 0.0018
704 PNEUMONITIS 49 0.0018
705 MOBILITY DECREASED 129 0.0018
706 MYALGIA 305 0.0018
707 CLOSTRIDIUM DIFFICILE COLITIS 19 0.0018
708 RASH PRURITIC 97 0.0018
709 JOINT RANGE OF MOTION DECREASED 24 0.0018
710 TASTE DISORDER 36 0.0018
711 PAIN IN JAW 50 0.0018
712 BODY TEMPERATURE INCREASED 36 0.0018
713 COLD SWEAT 31 0.0018
714 THERAPY CESSATION 90 0.0018
715 MEDICATION ERROR 97 0.0017
716 WOUND INFECTION 19 0.0017
717 GASTROINTESTINAL PAIN 19 0.0017
718 VERTIGO 105 0.0017
719 WHITE BLOOD CELL COUNT INCREASED 66 0.0017
720 RED BLOOD CELL SEDIMENTATION RATE INCREASED 19 0.0017
721 BLOOD PRESSURE DECREASED 114 0.0017
722 INTERSTITIAL LUNG DISEASE 83 0.0017
723 ANGINA PECTORIS 49 0.0017
724 DEVICE FAILURE 26 0.0017
725 SMALL INTESTINAL OBSTRUCTION 21 0.0017
726 METASTASES TO CENTRAL NERVOUS SYSTEM 22 0.0017
727 PROCEDURAL PAIN 47 0.0017
728 PYREXIA 584 0.0017
729 BALANCE DISORDER 145 0.0017
730 PARALYSIS 24 0.0017
731 BEDRIDDEN 22 0.0017
732 INTESTINAL OBSTRUCTION 63 0.0017
733 HYPOAESTHESIA 250 0.0017
734 NAUSEA 1319 0.0017
735 MUSCULOSKELETAL PAIN 87 0.0017
736 HYPOMAGNESAEMIA 23 0.0017
737 RESTLESS LEGS SYNDROME 30 0.0016
738 VENTRICULAR EXTRASYSTOLES 17 0.0016
739 SOMNOLENCE 329 0.0016
740 GALLBLADDER DISORDER 29 0.0016
741 SYNCOPE 162 0.0016
742 PAIN 990 0.0016
743 BLADDER DISORDER 16 0.0016
744 INCONTINENCE 17 0.0016
745 DECREASED APPETITE 373 0.0016
746 MUSCULAR WEAKNESS 182 0.0016
747 DEEP VEIN THROMBOSIS 104 0.0016
748 IMMUNE SYSTEM DISORDER 21 0.0016
749 HYPOAESTHESIA ORAL 24 0.0016
750 FULL BLOOD COUNT DECREASED 32 0.0016
751 INCORRECT DOSE ADMINISTERED 362 0.0016
752 GENERAL PHYSICAL HEALTH DETERIORATION 183 0.0016
753 THERAPY NON-RESPONDER 71 0.0016
754 STAPHYLOCOCCAL INFECTION 52 0.0016
755 INTERNAL HAEMORRHAGE 18 0.0016
756 DIARRHOEA 1015 0.0016
757 CEREBROVASCULAR ACCIDENT 266 0.0016
758 FREQUENT BOWEL MOVEMENTS 42 0.0016
759 HOT FLUSH 117 0.0016
760 GASTRIC DISORDER 53 0.0015
761 IMPAIRED WORK ABILITY 33 0.0015
762 HEPATIC CIRRHOSIS 29 0.0015
763 AMNESIA 100 0.0015
764 FOOT DEFORMITY 17 0.0015
765 INJECTION SITE RASH 47 0.0015
766 PERIPHERAL COLDNESS 21 0.0015
767 NEOPLASM MALIGNANT 102 0.0015
768 ANHEDONIA 40 0.0015
769 INFLUENZA LIKE ILLNESS 125 0.0015
770 RASH PAPULAR 34 0.0015
771 ANAEMIA 288 0.0015
772 DEVICE MALFUNCTION 106 0.0015
773 CHROMATURIA 34 0.0015
774 PRESCRIBED UNDERDOSE 30 0.0015
775 EYE HAEMORRHAGE 20 0.0015
776 THERAPY INTERRUPTED 107 0.0015
777 THERAPEUTIC PRODUCT EFFECT DECREASED 67 0.0015
778 IMPAIRED DRIVING ABILITY 17 0.0015
779 RENAL FAILURE 198 0.0015
780 JOINT STIFFNESS 39 0.0015
781 MEMORY IMPAIRMENT 203 0.0015
782 COLON CANCER 22 0.0015
783 UVEITIS 20 0.0015
784 DYSSTASIA 43 0.0015
785 DEHYDRATION 196 0.0015
786 BURNING SENSATION 103 0.0015
787 BRAIN FOG 23 0.0015
788 RESPIRATORY FAILURE 107 0.0015
789 FLATULENCE 83 0.0015
790 SPINAL PAIN 17 0.0014
791 HEPATIC STEATOSIS 27 0.0014
792 SKIN DISORDER 48 0.0014
793 DEPRESSED MOOD 76 0.0014
794 SKIN DISCOLOURATION 66 0.0014
795 HUNGER 20 0.0014
796 FAECES DISCOLOURED 31 0.0014
797 LABORATORY TEST ABNORMAL 42 0.0014
798 TENDONITIS 22 0.0014
799 DISABILITY 28 0.0014
800 BLISTER 79 0.0014
801 BURSITIS 17 0.0014
802 UNEVALUABLE EVENT 106 0.0014
803 LIVER DISORDER 62 0.0014
804 TACHYPNOEA 19 0.0014
805 TRANSAMINASES INCREASED 31 0.0014
806 PHOTOSENSITIVITY REACTION 23 0.0014
807 PRODUCT SUBSTITUTION ISSUE 80 0.0014
808 ARTHROPATHY 77 0.0014
809 URINARY INCONTINENCE 41 0.0014
810 PHOTOPHOBIA 26 0.0014
811 SYSTEMIC LUPUS ERYTHEMATOSUS 49 0.0014
812 TENDON RUPTURE 17 0.0014
813 INFLAMMATION 71 0.0014
814 MOVEMENT DISORDER 44 0.0014
815 BLOOD CREATININE INCREASED 89 0.0014
816 WOUND 38 0.0014
817 INJECTION SITE SWELLING 104 0.0014
818 ANGIOEDEMA 60 0.0014
819 PARAESTHESIA 213 0.0014
820 DIPLOPIA 35 0.0013
821 ERUCTATION 26 0.0013
822 PRODUCT PHYSICAL ISSUE 27 0.0013
823 TYPE 2 DIABETES MELLITUS 45 0.0013
824 ASPARTATE AMINOTRANSFERASE INCREASED 71 0.0013
825 NIGHT SWEATS 43 0.0013
826 HAEMORRHOIDS 26 0.0013
827 SKIN FISSURES 26 0.0013
828 CORONARY ARTERY DISEASE 40 0.0013
829 PNEUMONIA ASPIRATION 33 0.0013
830 LOSS OF CONSCIOUSNESS 168 0.0013
831 ARRHYTHMIA 62 0.0013
832 GLOMERULAR FILTRATION RATE DECREASED 16 0.0013
833 BLINDNESS 53 0.0013
834 CYST 16 0.0013
835 RASH MACULAR 45 0.0013
836 SKIN HAEMORRHAGE 19 0.0013
837 RHEUMATOID ARTHRITIS 144 0.0013
838 INJECTION SITE PRURITUS 84 0.0013
839 ADVERSE EVENT 115 0.0012
840 FLUID OVERLOAD 18 0.0012
841 HYPOTENSION 248 0.0012
842 HAEMATOMA 32 0.0012
843 ACUTE MYOCARDIAL INFARCTION 36 0.0012
844 BASAL CELL CARCINOMA 19 0.0012
845 MASS 17 0.0012
846 CRYING 44 0.0012
847 MUSCULOSKELETAL DISORDER 23 0.0012
848 BLINDNESS UNILATERAL 17 0.0012
849 POST PROCEDURAL COMPLICATION 23 0.0012
850 SEIZURE 138 0.0012
851 ACUTE KIDNEY INJURY 182 0.0012
852 DEAFNESS 31 0.0012
853 SKIN EXFOLIATION 100 0.0012
854 SENSORY DISTURBANCE 19 0.0012
855 LETHARGY 68 0.0012
856 DRY SKIN 155 0.0012
857 INJECTION SITE BRUISING 92 0.0012
858 BONE DISORDER 21 0.0012
859 INCREASED APPETITE 22 0.0012
860 BONE DENSITY DECREASED 36 0.0011
861 COLITIS ULCERATIVE 51 0.0011
862 CARDIAC ARREST 94 0.0011
863 FLUSHING 115 0.0011
864 EATING DISORDER 24 0.0011
865 SKIN ULCER 29 0.0011
866 INJECTION SITE ERYTHEMA 138 0.0011
867 RENAL INJURY 33 0.0011
868 TOOTH LOSS 23 0.0011
869 PSORIATIC ARTHROPATHY 45 0.0011
870 MENTAL DISORDER 48 0.0011
871 CARDIOVASCULAR DISORDER 28 0.0011
872 GASTRITIS 29 0.0011
873 MOOD ALTERED 30 0.0011
874 ERYTHEMA 226 0.0011
875 RECTAL HAEMORRHAGE 47 0.0011
876 SKIN LESION 30 0.0011
877 RASH ERYTHEMATOUS 52 0.0011
878 RED BLOOD CELL COUNT DECREASED 31 0.0011
879 HAEMOGLOBIN DECREASED 111 0.0011
880 RENAL DISORDER 50 0.0011
881 HAEMATOCHEZIA 59 0.0011
882 FACE OEDEMA 18 0.0011
883 CARDIAC FAILURE 85 0.0011
884 FRACTURE 20 0.0011
885 INFUSION RELATED REACTION 70 0.0011
886 MENTAL STATUS CHANGES 29 0.0010
887 DEATH 892 0.0010
888 INJECTION SITE PAIN 316 0.0010
889 APHASIA 31 0.0010
890 PSYCHOMOTOR HYPERACTIVITY 17 0.0010
891 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 30 0.0010
892 HYPOPHAGIA 26 0.0010
893 DEVICE ISSUE 91 0.0010
894 IRRITABILITY 61 0.0010
895 IMPAIRED HEALING 33 0.0010
896 GASTRIC ULCER 19 0.0010
897 BLOOD GLUCOSE DECREASED 48 0.0010
898 CONFUSIONAL STATE 161 0.0010
899 CONTRAINDICATED PRODUCT ADMINISTERED 30 0.0010
900 MENTAL IMPAIRMENT 24 0.0010
901 HAEMORRHAGE 103 0.0010
902 DISTURBANCE IN ATTENTION 53 0.0010
903 NIGHTMARE 34 0.0010
904 BLOOD GLUCOSE ABNORMAL 18 0.0010
905 FEAR 26 0.0010
906 NEEDLE ISSUE 28 0.0010
907 MOUTH ULCERATION 20 0.0009
908 LEUKOCYTOSIS 17 0.0009
909 HYPOKALAEMIA 43 0.0009
910 PRURITUS GENERALISED 20 0.0009
911 INCORRECT PRODUCT ADMINISTRATION DURATION 20 0.0009
912 INTENTIONAL OVERDOSE 59 0.0009
913 ACCIDENTAL EXPOSURE TO PRODUCT 94 0.0009
914 DERMATITIS 19 0.0009
915 PSORIASIS 118 0.0009
916 INJECTION SITE URTICARIA 22 0.0009
917 DISEASE PROGRESSION 106 0.0009
918 DISORIENTATION 35 0.0009
919 INCORRECT DOSE ADMINISTERED BY DEVICE 23 0.0009
920 GLYCOSYLATED HAEMOGLOBIN INCREASED 22 0.0009
921 COLITIS 33 0.0009
922 BLOOD GLUCOSE INCREASED 164 0.0009
923 MELAENA 19 0.0009
924 ALOPECIA 164 0.0008
925 PANCREATITIS 44 0.0008
926 PRODUCT PREPARATION ERROR 17 0.0008
927 SEPTIC SHOCK 36 0.0008
928 INJECTION SITE WARMTH 17 0.0008
929 GASTROINTESTINAL HAEMORRHAGE 68 0.0008
930 DYSKINESIA 33 0.0008
931 NO ADVERSE EVENT 147 0.0008
932 HALLUCINATION, VISUAL 17 0.0008
933 ANGER 27 0.0008
934 C-REACTIVE PROTEIN INCREASED 29 0.0008
935 ABDOMINAL PAIN LOWER 20 0.0008
936 HAEMATEMESIS 20 0.0008
937 HAEMATURIA 27 0.0008
938 INJECTION SITE MASS 29 0.0008
939 FEMUR FRACTURE 24 0.0008
940 RASH GENERALISED 20 0.0008
941 PLASMA CELL MYELOMA 30 0.0008
942 RESTLESSNESS 28 0.0008
943 VISUAL ACUITY REDUCED 25 0.0008
944 PAIN OF SKIN 20 0.0007
945 EXPOSURE DURING PREGNANCY 46 0.0007
946 DRUG DOSE OMISSION BY DEVICE 56 0.0007
947 INJECTION SITE HAEMORRHAGE 57 0.0007
948 HYPERGLYCAEMIA 26 0.0007
949 PLATELET COUNT DECREASED 76 0.0007
950 INJECTION SITE REACTION 49 0.0007
951 COGNITIVE DISORDER 33 0.0007
952 EMOTIONAL DISTRESS 85 0.0007
953 DYSARTHRIA 26 0.0007
954 INCORRECT ROUTE OF DRUG ADMINISTRATION 24 0.0007
955 DRUG INTERACTION 106 0.0007
956 RENAL IMPAIRMENT 56 0.0007
957 ANAPHYLACTIC SHOCK 17 0.0007
958 WHITE BLOOD CELL COUNT DECREASED 71 0.0007
959 DELIRIUM 22 0.0006
960 PALLOR 17 0.0006
961 ABNORMAL DREAMS 17 0.0006
962 OSTEONECROSIS 20 0.0006
963 SUICIDAL IDEATION 53 0.0006
964 BREAST CANCER 53 0.0006
965 WITHDRAWAL SYNDROME 23 0.0005
966 SKIN IRRITATION 25 0.0005
967 INJURY 37 0.0005
968 MULTIPLE SCLEROSIS RELAPSE 35 0.0005
969 TREATMENT FAILURE 42 0.0005
970 PROSTATE CANCER 40 0.0005
971 DEVICE BREAKAGE 20 0.0005
972 SKIN BURNING SENSATION 35 0.0005
973 ACNE 37 0.0005
974 BRADYCARDIA 25 0.0005
975 MATERNAL EXPOSURE DURING PREGNANCY 41 0.0005
976 LEUKOPENIA 23 0.0005
977 DEVICE LEAKAGE 19 0.0004
978 DEVICE DIFFICULT TO USE 29 0.0004
979 VAGINAL HAEMORRHAGE 19 0.0004
980 FEBRILE NEUTROPENIA 28 0.0004
981 MULTIPLE SCLEROSIS 20 0.0004
982 NEUTROPHIL COUNT DECREASED 17 0.0004
983 ALANINE AMINOTRANSFERASE INCREASED 22 0.0004
984 PANCYTOPENIA 20 0.0004
985 NEUTROPENIA 48 0.0004
986 MALIGNANT NEOPLASM PROGRESSION 34 0.0003
987 BLADDER CANCER 17 0.0003
988 THROMBOCYTOPENIA 30 0.0003
989 DRUG DEPENDENCE 37 0.0002
990 DRUG WITHDRAWAL SYNDROME 16 0.0002